21+ Mast Cell Stabilizers For MCAS Treatment

In my forty years treating patients with chronic complex illness, I have rarely encountered a patient population as rigorously self-educated as those that walk through my door with a Mast Cell Activation Syndrome (MCAS) diagnosis. MCAS has only been formally recognised in mainstream medicine since 2010, though the condition itself is far older, and in that gap between disease and diagnosis, patients have had no choice but to become their own investigators and self advocates, often being way more informed than their doctors.

What I observe consistently is that even the most educated patients are working from an incomplete picture and most often without directed clinical guidelines. They have access to a list of treatment options but very rarely have the clinical detail that determines whether those options actually work: which natural compounds have the strongest evidence and at what dose, which pharmaceuticals are most likely to produce unexpected reactions and why, which combinations are redundant and which are genuinely synergistic. In particular, they don’t have the clinical experience of what treatment to start, when to use them and how often to give the treatment. Also, what to do or not to do should their attempts not be successful. In a previous article I explored one example of this; the excipients hidden inside medications that are frequently the source of a reaction patients attribute to the drug itself. This article addresses the full treatment picture.

What follows in the Substack article below is the complete treatment framework I use in practice. It covers:

• My A, B, and C teams of natural mast cell stabilisers ranked by clinical potency with specific dosing, and the COMT genetic variant that makes two of the most commonly recommended supplements actively harmful for a subset of patients

• The full pharmaceutical toolkit from H1 and H2 blockers through to low-dose naltrexone and IV immunoglobulin, including why the same drug can stabilise one patient and destabilise another, and why that reaction is usually an excipient problem, not a drug problem

• How to increase histamine breakdown at the enzymatic level, and why alcohol combined with aged cheese can unravel weeks of stabilisation in a single evening

• The specific probiotic strains that degrade histamine versus those that produce it, a distinction almost never addressed in standard MCAS guidance

• The upstream factors most protocols never reach: gut dysbiosis, occult infections, circadian disruption, and magnesium deficiency as a direct driver of mast cell emergence

When it comes to MCAS, the devil is in the details. I have watched highly resourced and deeply motivated patients spend years cycling through treatments that should have helped them but didn’t, purely for the lack of the specific clinical precision that determines whether treatment is successful. If you want a comprehensive clinical reference for treating MCAS with medications and supplements, this article below provides exactly that.

If you want a more all round description of the entire MCAS and POTS picture: the cellular biology of mast cell dysregulation, the Consensus 2 diagnostic criteria, the POTS connection most practitioners miss, the Triad, Pentad, and Septad framework that explains why so many of these patients present with overlapping conditions and the complete treatment logic from first principles to clinical practice, my MCAS & POTS Deep Dive Lecture covers all of it in three hours.